SCHEMBL3968192

SCHEMBL3968192

[O]CC1(C(F)F)N=c2ccccc2=N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3970831 0.79 KDM4E (0.33)
SCHEMBL3973658 0.68 KDM4E (0.30)
SCHEMBL3974680 0.67
SCHEMBL4191636 0.67 KDM4E (0.35)
SCHEMBL3968506 0.67
SCHEMBL3969182 0.65 BACE1 (0.34)
SCHEMBL3968216 0.64 KDM4E (0.31)
SCHEMBL3968948 0.64 KDM4E (0.33)
SCHEMBL3970496 0.62 KDM4E (0.33)
SCHEMBL3972388 0.62 KDM4E (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7595317-B2 Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinases BRISTOL-MYERS SQUIBB COMPANY (US) 2009-09-29 US disclosed
US-7294624-B2 Osteoporosis; antiarthritic agents BRISTOL MYERS SQUIBB COMPANY (US) 2007-11-13 US disclosed
US-20070167451-A1 BARBITURIC ACID DERIVATIVES AS INHIBITORS OF TNF-alpha CONVERTING ENZYME (TACE) AND/OR MATRIX METALLOPROTEINASES DUAN JINGWU 2007-07-19 US disclosed